Multicyclic compounds and the use thereof
US8716493B2 · kind B2 · utility
2Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 2010 |
| Grant date | May 6, 2014 |
| Priority date | — |
| Expiry date | Aug 10, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.